Search results
Results from the WOW.Com Content Network
The approval was updated in September 2021, to include people aged twelve and older. [14] The Moderna Spikevax COVID-19 vaccine was authorized in Canada in September 2021, for people aged 12 and older. [22] [4] [182] The Moderna Spikevax COVID-19 vaccine was authorized in the US in January 2022, for people aged 18 and older. [1] [38] [41]
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
In March 2020, the Food and Drug Administration approved clinical trials for the Moderna COVID‑19 vaccine candidate, and in December, the vaccine, mRNA-1273, was issued an emergency use authorization in the United States. [35] [36] In 2022, it gained FDA approval both for the monovalent vaccine, Spikevax, and a bivalent booster. [37]
Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron ...
On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which targets the SARS-CoV-2 variant JN.1. The submission is ...
Moderna Inc (NASDAQ: MRNA) reported Thursday ahead of the market open with a first-quarter loss that came in line with expectations and also issued an update on its coronavirus vaccine program.The ...
Yahoo Finance’s Brian Sozzi and Alexis Christoforous break down the market action for Moderna, after the company announced it received FDA clearance for its coronavirus vaccine for phase 2 trial.
The FDA authorizes the first bivalent COVID-19 booster for ages 5-11. ... Moderna's COVID-19 boosters for ages 5 and up ... 2022 at 10:24 AM. The CDC approved Pfizer/BioNTech's (PFE/BNTX) bivalent ...